Maureen Testoni, president and CEO of 340B Health, Jason Reddish, a principal at Powers Law, and Ross Margulies, a partner at Foley Hoag, discussed the looming uncertainty in 340B following a key federal district court ruling during the 340B Coalition Winter Conference.
Genesis Ruling Creates Legal, Regulatory Uncertainty for 340B, Says Attorney Panel
A recent federal district court ruling on the 340B patient definition created a “gray area” for 340B providers and drugmakers, [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
